In a significant legal development, orthopedic providers have filed a lawsuit against a coalition of major insurers, including Elevance, UnitedHealthcare, Aetna, Cigna, and others, alleging their participation in a multibillion-dollar price-fixing scheme aimed at suppressing payment rates for out-of-network medical services. The lawsuit, filed Monday in federal court in Illinois, accuses the insurers and MultiPlan, a third-party repricing service, of colluding to reduce reimbursement rates for out-of-network healthcare providers, violating antitrust laws in the process.
Background of the Lawsuit
The lawsuit has been brought forward by Advanced Orthopedic Center and Dr. Curtis F. Robinson, operating under Panoramic Medicine, which represents a class of healthcare providers who submit out-of-network claims to insurers. The plaintiffs allege that insurers, in concert with MultiPlan, manipulated out-of-network payment rates in ways that hurt providers financially.
The full list of defendants named in the suit includes prominent players in the healthcare and insurance industry: MultiPlan, Aetna, Blue Cross Blue Shield affiliates (BSCA, BCBSMI, BCBSMN), Centene, Cigna, Elevance, Health Care Service Corporation (HCSC), Humana, Kaiser, Molina, UnitedHealthcare, and others. These companies collectively dominate the health insurance market, serving millions of Americans with preferred provider organization (PPO) plans that allow members to see out-of-network providers at a reduced rate.
The plaintiffs are seeking class-action status, a jury trial, a determination that the conduct described in the lawsuit is unlawful, and financial restitution for damages. The claim details the operations of MultiPlan, which, according to the plaintiffs, acts as a “cartel” that determines out-of-network compensation rates for the entire healthcare industry, suppressing payments to healthcare providers in the process.
The Alleged Price-Fixing Scheme
The crux of the plaintiffs’ complaint is that insurers are engaging in a coordinated effort to suppress out-of-network payment rates by outsourcing the rate-setting function to MultiPlan. In traditional insurance models, out-of-network providers are reimbursed based on a negotiated rate, often a discount from the provider’s retail charge. However, in this case, the plaintiffs allege that the insurers have effectively colluded to keep out-of-network rates artificially low.
The lawsuit claims that insurers, including some of the largest companies in the industry, collectively turn to MultiPlan to set rates for out-of-network services. MultiPlan, which has seen its revenues skyrocket from $23 million in 2012 to over $700 million in recent years, is accused of using an “algorithmic” system called Data iSight to determine these rates. However, the plaintiffs argue that Data iSight is a “technological smokescreen” for traditional price-fixing, a practice that undermines fair market competition and harms healthcare providers.
The complaint highlights that insurers give MultiPlan real-time, confidential data about their pricing strategies, including the amounts they pay for in-network and out-of-network services. This exchange of information allegedly enables MultiPlan to suppress compensation rates across the healthcare industry, ultimately harming providers who rely on fair reimbursement for their services.
Why It Matters: The Impact on Providers and Patients
The allegations in this lawsuit represent a direct challenge to the way out-of-network services are compensated in the U.S. healthcare system. The plaintiffs argue that insurers and MultiPlan are effectively operating as a “cartel,” artificially reducing payments to providers by sharing sensitive pricing information. This has led to a situation where many providers, particularly in specialties like orthopedics, are left with lower reimbursement rates for services that are not covered under patients’ in-network plans.
For healthcare providers, especially those working in independent or specialty practices, the financial impact of these allegedly suppressed payment rates is significant. In a healthcare landscape already strained by rising operational costs and increasing administrative burdens, these lower reimbursement rates can undermine the ability of providers to maintain their practices and continue offering high-quality care.
Patients, too, are caught in the middle. While PPO plans allow patients to access out-of-network providers, they are often faced with higher costs when seeking care outside of their insurer’s network. If the providers are not compensated fairly, they may be forced to either reduce the scope of services they offer or pass those costs onto patients.
Moreover, the scheme allegedly reduces the overall availability of care in certain specialties, as providers who cannot afford to operate at reduced rates may be pushed out of business or forced to limit the number of patients they can treat. This could have a cascading effect on access to medical services, particularly in areas where out-of-network providers are crucial to maintaining patient access to care.
The Larger Trend: Price-Fixing in Healthcare
The lawsuit against MultiPlan and the major insurers is part of a broader trend of growing concern over price-fixing and anti-competitive behavior in the healthcare industry. Over the past few years, numerous investigations and lawsuits have exposed collusion among healthcare organizations that resulted in inflated prices for medical services and prescription drugs. This new lawsuit highlights a particular aspect of price-fixing—how insurers may be working together to suppress payment rates for out-of-network care, an area that traditionally offers providers the freedom to negotiate their own reimbursement rates.
The success of MultiPlan’s repricing services, which have grown from $23 million in 2012 to $709 million in 2021, demonstrates the growing centralization of power in the hands of a few major players. MultiPlan’s algorithmic approach to determining out-of-network compensation rates has attracted criticism for its opacity and its potential to stifle competition in the healthcare industry.
While the details of the case will unfold in court, the lawsuit underscores the increasing financial pressure that healthcare providers are facing in an industry dominated by large insurance companies and third-party service providers like MultiPlan. It also raises important questions about the ethical and legal implications of insurers working together to suppress compensation rates in a way that could negatively impact the quality of care patients receive.
The Legal Landscape: Antitrust Issues and Class Action Status
The legal theory behind the plaintiffs’ case centers around antitrust laws, specifically the Sherman Antitrust Act, which prohibits price-fixing and other anti-competitive practices that harm consumers. If the court grants class-action status, the case could expand to include thousands of healthcare providers across the country who have been affected by the alleged price-fixing scheme. The plaintiffs argue that this behavior constitutes an unlawful conspiracy that violates fair competition laws and results in significant financial harm to healthcare providers.
A key element of the lawsuit is the request for a jury trial, which could lead to a public examination of the practices employed by MultiPlan and the insurance giants it collaborates with. If successful, the lawsuit could force insurers and MultiPlan to pay damages to affected providers, as well as make changes to their pricing practices and transparency in how out-of-network rates are determined.
What’s Next?
As this case moves forward, the impact on the healthcare industry could be far-reaching. If the court rules in favor of the plaintiffs, it could lead to significant changes in how out-of-network compensation rates are determined, and how insurers interact with third-party services like MultiPlan. Healthcare providers who have been financially harmed by these alleged practices may have a chance to recoup damages and gain a clearer understanding of how reimbursement rates are set in the future.
While the outcome of this lawsuit is uncertain, it has already brought attention to the issue of price-fixing and anti-competitive behavior within the healthcare industry. For providers, patients, and insurers alike, this case could mark a turning point in the ongoing fight for fair compensation in the U.S. healthcare system.
As the legal process unfolds, it is important for all stakeholders in the healthcare industry—especially providers—to stay informed about the case and consider its potential implications on future pricing structures and business practices. Whether or not the lawsuit results in a favorable outcome for the plaintiffs, it has already sparked critical conversations about the future of healthcare pricing and the need for greater transparency and fairness in the industry.
Discover more from Doctor Trusted
Subscribe to get the latest posts sent to your email.
